Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value(s)

15 Oct 2020 07:00

RNS Number : 1266C
Agronomics Limited
15 October 2020
 

15 October 2020

Agronomics Limited

(the "Company")

Net Asset Value calculation to 30 September 2020

Agronomics Limited (AIM:ANIC), a leading listed investor in cellular agriculture with a focus on cultivated meat and alternative proteins, announces that its Net Asset Valuation ("NAV") calculation as at closing on 30 September 2020 was 5.62 pence per share, including un-invested cash of £0.3 million. The portfolio is valued under IFRS at bid price. The share price of 5 pence at the 30 September 2020 close represents a discount of 13.85% to the NAV. Net Assets stand at £18.6 million, including investments of £20.4 million. This quarter's NAV per share represents a decrease of 1% from the previous quarters NAV of 5.68 pence per share, which included un-invested cash of £2.8 million. No management fee is due to Shellbay Investments Limited.

Following the draw-down of the Galloway Limited loan facility in September 2020, the Company completed two investments during the quarter.

 

The Company acquired 1,127 Series A Preferred Shares in Solar Foods Oy, for a consideration of EUR 3 million. Solar Foods develops a sustainable protein called Solein®, a microorganism that grows utilising airborne carbon dioxide and hydrogen via the electrolysis of water.

 

As part of a US$ 55 million financing lead by Blue Horizon Ventures, the Company invested an initial US$ 2.05 million in Mosa Meats B.V.. In total, Agronomics has committed to investment of US$ 4.1 million into Mosa Meats B.V with the financing being split into two tranches. Mosa Meat is a cultivated meat company based in the Netherlands, whose founding scientist, Professor Mark Post, showcased the world's first cultivated burger in 2013. Mosa Meat is focused initially on cultivated beef products, intending to have products approved in the EU in 2023.

 

Towards the end of September 2020, Shiok Meats Pte. Ltd completed a Series A financing. Following this, the convertible loan note investment, plus accrued interest to date, converted into Series A Preferred Shares at a 20% discount. This resulted in a 28% uplift to the carrying value of our investment in Shiok Meats.

 

Since the start of January 2020, the outbreak of coronavirus, which is a rapidly evolving situation, has adversely impacted global commercial activities. The rapid development and fluidity of this situation precludes any prediction as its ultimate impact, which may have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The Directors do not believe there is any direct financial impact on the Company, but we continue to monitor any impact on both the Company and its investee holdings.

Unaudited to

30 September 2020 £

Fixed Assets

Investments

20,430,818

Current Assets

Uninvested Cash

301,551

Sundry Debtors

32,450

Current Liabilities

Trade and Other Creditors

(218,278)

Loan Advances

(1,900,000)

18,646,541

Capital and Reserves

Share Capital

23

Share Premium

19,578,859

Retained Earnings

(932,341)

18,646,541

Shares in Issue

331,616,661

Net Asset Value per share

5.62 pence

 

Portfolio Details

Investments as at 30 September 2020

Value (£)

% of Total Portfolio

Quoted holdings

447,765

2.2%

Unquoted holdings

19,983,053

97.8%

Total

20,430,818

100%

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Cenkos Securities Plc

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Giles Balleny

Max Gould

Michael Johnson (Broking)

+44 (0) 20 7937 8900

Lucy Williams

+44 (0) 207 469 0936

 

Tim Blackstone

+44 (0)7957 140416

 

 

About Agronomics

Agronomics is a leading listed investor in cellular agriculture with a focus on cultivated meat and alternative proteins.

 

The Company invests in technologies that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population.

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBLBDGISBDGGS
Date   Source Headline
14th Mar 20227:00 amRNSAgronomics Follow on Investment in GALY CO.
8th Mar 20227:00 amRNSAgronomics co-leads SuperMeat’s Series A Financing
24th Feb 20227:00 amRNSAgronomics welcomes Senior Investment Associate
22nd Feb 20227:00 amRNSAgronomics Leads Onego Bio's Seed Funding Round
21st Feb 20228:33 amRNSAgronomics Acquires Stake in Geltor, Inc
3rd Feb 20227:00 amRNSInterim Results
2nd Feb 202212:17 pmRNSResult of AGM
27th Jan 20228:00 amRNSPortfolio Company Update: BlueNalu
10th Jan 20228:12 amRNSExercise of Warrants
24th Dec 202111:51 amRNSHolding(s) in Company
23rd Dec 20211:11 pmRNSHolding(s) in Company
23rd Dec 202110:53 amRNSAgronomics December 2021 Newsletter
21st Dec 20212:29 pmRNSOpen Offer Results Subscription PDMR Dealing & TVR
16th Dec 20217:00 amRNSFinal Results and Notice of AGM
10th Dec 202111:08 amRNSHolding(s) in Company
8th Dec 20218:30 amRNSPortfolio Company Update: The EVERY Company
2nd Dec 20211:30 pmRNSResults of the Placing and Subscription
1st Dec 202111:30 amRNSProposed Fundraise to raise minimum £25 million
19th Nov 20217:00 amRNSAgronomics Leads Ohayo Valley’s Pre-Seed Funding
11th Nov 20217:00 amRNSPortfolio Company Update: Tropic Biosciences
5th Nov 20217:00 amRNSNet Asset Value calculation to 30 September 2021
4th Nov 20217:00 amRNSUS$ 8 million investment in The EVERY Company
3rd Nov 20217:00 amRNSAnnounces Launch of New Website
26th Oct 20217:00 amRNSAgronomics EUR3 million investment in Solar Foods
26th Oct 20217:00 amRNSInSilico Medicine sale-Correction of sale proceeds
20th Oct 20218:00 amRNSAgronomics leads investment in California Cultured
12th Oct 20217:00 amRNSExercise of Warrants and Updated TVR
29th Sep 20217:00 amRNSAnnounces Sale of Oritain Shares
28th Sep 20217:00 amRNSNew Age Meats Announces US$ 25 million Series A
22nd Sep 20212:48 pmRNSPortfolio Company Update: Mosa Meat
20th Sep 20217:00 amRNSAgronomics leads VitroLabs Series A Funding
14th Sep 20217:00 amRNSPortfolio Company Update: BlueNalu
14th Sep 20217:00 amRNSPortfolio Company Update: Meatable
13th Sep 20218:00 amRNSSubscription in Formo’s US $50 million Fundraise
30th Jul 20215:34 pmRNSReplacement: Net Asset Valuation to 30 June 2021
30th Jul 202112:02 pmRNSNet Asset Value calculation to 31 June 2021
21st Jul 20211:15 pmRNSPortfolio Company Update: Shiok Meats Pte. Ltd
15th Jul 20217:00 amRNSWarrants to be traded on J P Jenkins
14th Jul 20217:00 amRNSTwo portfolio companies in XPRIZE semi-finals
13th Jul 20217:00 amRNSHalf Year Newsletter
25th Jun 20214:21 pmRNSPortfolio Company LIVEKINDLY Update
24th Jun 20215:03 pmRNSPortfolio Company Formo Update
24th Jun 20217:00 amRNSAnnounces the Sale of InSilico Medicine Inc Shares
28th May 202112:10 pmRNSResults of General Meeting, Issue of Equity & TVR
28th May 20217:00 amRNSAnnounces the Conversion of CellX SAFE
27th May 20217:00 amRNSBroker Option Results
25th May 20217:00 amRNSUpdate regarding Broker Option
20th May 20217:00 amRNSUpdate regarding Broker Option
13th May 20217:00 amRNSAnnounces Secondary Purchase of Shares in Meatable
12th May 20217:00 amRNSResult of Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.